Home LiteratureArticle Details
PMID: 15946423 Published · ppublish English Comparative Study Journal Article Review

Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.

Obesity surgery ·Vol. 15 ·No. 4 ·2005-04-00 ·Pages 462-73

Gumbs AA, Modlin IM, Ballantyne GH

Abstract

The prevalence of type 2 diabetes mellitus (T2DM) and obesity in the western world is steadily increasing. Bariatric surgery is an effective treatment of T2DM in obese patients. The mechanism by which weight loss surgery improves glucose metabolism and insulin resistance remains controversial. In this review, we propose that two mechanisms participate in the improvement of glucose metabolism and insulin resistance observed following weight loss and bariatric surgery: caloric restriction and weight loss. Nutrients modulate insulin secretion through the entero-insular axis. Fat mass participates in glucose metabolism through the release of adipocytokines. T2DM improves after restrictive and bypass procedures, and combinations of restrictive and bypass procedures in morbidly obese patients. Restrictive procedures decrease caloric and nutrient intake, decreasing the stimulation of the entero-insular axis. Gastric bypass (GBP) operations may also affect the entero-insular axis by diverting nutrients away from the proximal GI tract and delivering incompletely digested nutrients to the distal GI tract. GBP and biliopancreatic diversion combine both restrictive and bypass mechanisms. All procedures lead to weight loss and decrease in the fat mass. Decrease in fat mass significantly affects circulating levels of adipocytokines, which favorably impact insulin resistance. The data reviewed here suggest that all forms of weight loss surgery lead to caloric restriction, weight loss, decrease in fat mass and improvement in T2DM. This suggests that improvements in glucose metabolism and insulin resistance following bariatric surgery result in the short-term from decreased stimulation of the entero-insular axis by decreased caloric intake and in the long-term by decreased fat mass and resulting changes in release of adipocytokines. Observed changes in glucose metabolism and insulin resistance following bariatric surgery do not require the posit of novel regulatory mechanisms.

MeSH Terms
Biomarkers/metabolism Blood Glucose/analysis Body Mass Index Caloric Restriction Diabetes Mellitus, Type 2/complications,diagnosis,physiopathology Energy Metabolism Female Gastric Bypass/methods Gastric Inhibitory Polypeptide/metabolism Ghrelin Glucagon/metabolism Glucagon-Like Peptide 1 Humans Insulin Resistance Male Obesity, Morbid/complications,diagnosis,surgery Peptide Fragments/metabolism Peptide Hormones/metabolism Prognosis Protein Precursors/metabolism Treatment Outcome Weight Loss
Chemicals
Biomarkers Blood Glucose Ghrelin Peptide Fragments Peptide Hormones Protein Precursors Gastric Inhibitory Polypeptide Glucagon-Like Peptide 1 Glucagon
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Gumbs Andrew A
Department of Surgery, Yale University School of Medicine, New Haven, CT, USA.
Modlin Irvin M
Ballantyne Garth H
Article Info
Journal
Obesity surgery
Abbr.
Obes Surg
ISSN
0960-8923
Published
2005-04-00
Pages
462-73
Language
English
Region
United States
NLM ID
9106714
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]